Jul 05, 2018

What Is Glioblastoma? HCI Brain Tumor Experts Explain

We asked the experts at Huntsman Cancer Institute about symptoms, diagnosis, and treatment of glioblastoma.

Jun 05, 2018

Back on the Slopes after Brain Cancer

John Karg was diagnosed with glioblastoma, a type of brain cancer, early in 2016. His cancer care team at Huntsman Cancer Institute treated the cancer with surgery, radiation, oral chemotherapy, and participation in clinical trials. He’s doing very well with the treatment—his interview for this article happened while he was waiting for the lift lines at Alta ski resort.

Feb 15, 2018

Total Cancer Care: Coming Together to Find Cures

Christina Ratcliff enrolled in HCI's Total Cancer Care study, a partnership among patients, health care providers, and researchers to help accelerate cancer research and improve patient care.

Jan 24, 2018

Kirk Bengtzen's Reason to Give

"One thing is for sure: cancer will affect your life... and the only way we're going to find a cure is by supporting research."

Nov 27, 2017

Talks with Docs: Randy Jensen, MD, PhD

Dr. Randy Jensen—auto racer, canyoneer, triathlete, and neurosurgeon—chats with us about his many life adventures.

Sep 13, 2017

What to Expect with Stereotactic Radiosurgery

What should you expect before, during, and after stereotactic radiosurgery, or SRS? This video explains the process and may help you feel less anxious when facing your first SRS appointment.

May 15, 2017

Words of Hope for Brain Tumor Awareness Month

For Brain Tumor Awareness Month, Randy Jensen, MD, PhD, wants you to know something: “There is a lot of hope for patients with brain tumors.”

Oct 27, 2016

Promise of Better Targeted Treatments Now Possible in Children’s Brain Cancer

SALT LAKE CITY—More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer. Writing this week in the journal Cell Reports, researchers at Huntsman Cancer Institute (HCI) at the University of Utah report they have identified an existing group of drugs that appear to reduce or eliminate a certain subgroup of childhood brain cancers while sparing normal brain tissue. The research was conducted using a new zebrafish animal model system developed by the researchers, which closely resembles an aggressive subtype of pediatric brain tumors.